The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Myfortic 180 mg gastro-resistant tablets

Novartis Ireland LimitedPA0896/023/001

Main Information

Trade NameMyfortic 180 mg gastro-resistant tablets
Active SubstancesMycophenolic acid
Dosage FormGastro-resistant tablet
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/023/001

Group Information

ATC CodeL04AA Selective immunosuppressants
L04AA06 mycophenolic acid


License statusAuthorised
Licence Issued02/07/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

« Back